These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 27785023)
61. Discovery of a novel highly potent and low-toxic jatrophane derivative enhancing the P-glycoprotein-mediated doxorubicin sensitivity of MCF-7/ADR cells. Maimaitijiang A; Wang B; Yang H; Tang D; Liu Y; Aisa HA Eur J Med Chem; 2022 Dec; 244():114822. PubMed ID: 36242992 [TBL] [Abstract][Full Text] [Related]
62. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR. Shen J; Wang Q; Hu Q; Li Y; Tang G; Chu PK Biomaterials; 2014 Oct; 35(30):8621-34. PubMed ID: 25002258 [TBL] [Abstract][Full Text] [Related]
63. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells. Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460 [TBL] [Abstract][Full Text] [Related]
64. Enhanced delivery of quercetin and doxorubicin using β-cyclodextrin polymer to overcome P-glycoprotein mediated multidrug resistance. Pawar CS; Rajendra Prasad N; Yadav P; Muthu Vijayan Enoch IV; Manikantan V; Dey B; Baruah P Int J Pharm; 2023 Mar; 635():122763. PubMed ID: 36822336 [TBL] [Abstract][Full Text] [Related]
65. Mechanism study of PEGylated polyester and β-cyclodextrin integrated micelles on drug resistance reversal in MRP1-overexpressed HL60/ADR cells. Ji Q; Qiu L Colloids Surf B Biointerfaces; 2016 Aug; 144():203-213. PubMed ID: 27088190 [TBL] [Abstract][Full Text] [Related]
66. Active targeting co-delivery system based on pH-sensitive methoxy-poly(ethylene glycol)2K-poly(ε-caprolactone)4K-poly(glutamic acid)1K for enhanced cancer therapy. Li N; Huang C; Luan Y; Song A; Song Y; Garg S J Colloid Interface Sci; 2016 Jun; 472():90-8. PubMed ID: 27016914 [TBL] [Abstract][Full Text] [Related]
67. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells. Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866 [TBL] [Abstract][Full Text] [Related]
68. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer. Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372 [TBL] [Abstract][Full Text] [Related]
69. mPEG-b-PCL/TPGS mixed micelles for delivery of resveratrol in overcoming resistant breast cancer. Wang S; Chen R; Morott J; Repka MA; Wang Y; Chen M Expert Opin Drug Deliv; 2015 Mar; 12(3):361-73. PubMed ID: 25392124 [TBL] [Abstract][Full Text] [Related]
70. Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies. Li B; Xu H; Li Z; Yao M; Xie M; Shen H; Shen S; Wang X; Jin Y Int J Nanomedicine; 2012; 7():187-97. PubMed ID: 22275834 [TBL] [Abstract][Full Text] [Related]
71. Enhanced drug resistance suppression by serum-stable micelles from multi-arm amphiphilic block copolymers and tocopheryl polyethylene glycol 1000 succinate. He L; Jiang C; Ren J; Pan X; Qiu Z; Xia Y; Wang T; Guo J; Li J; Li W Nanomedicine (Lond); 2024; 19(14):1297-1311. PubMed ID: 39046514 [TBL] [Abstract][Full Text] [Related]
72. Poly(L-lactide)-vitamin E TPGS nanoparticles enhanced the cytotoxicity of doxorubicin in drug-resistant MCF-7 breast cancer cells. Li PY; Lai PS; Hung WC; Syu WJ Biomacromolecules; 2010 Oct; 11(10):2576-82. PubMed ID: 20722436 [TBL] [Abstract][Full Text] [Related]
73. Overcoming multidrug resistance of breast cancer cells by the micellar doxorubicin nanoparticles of mPEG-PCL-graft-cellulose. Chen CH; Cuong NV; Chen YT; So RC; Liau I; Hsieh MF J Nanosci Nanotechnol; 2011 Jan; 11(1):53-60. PubMed ID: 21446406 [TBL] [Abstract][Full Text] [Related]
74. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433 [TBL] [Abstract][Full Text] [Related]
75. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition. Gao M; Xu Y; Qiu L J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110 [TBL] [Abstract][Full Text] [Related]
76. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice. Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524 [TBL] [Abstract][Full Text] [Related]
77. Comparison of hyaluronic acid-based micelles and polyethylene glycol-based micelles on reversal of multidrug resistance and enhanced anticancer efficacy in vitro and in vivo. Wang J; Li Y; Wang L; Wang X; Tu P Drug Deliv; 2018 Nov; 25(1):330-340. PubMed ID: 29350064 [TBL] [Abstract][Full Text] [Related]
78. Chemosensitization of doxorubicin in multidrug-resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis. Wang M; Han M; Li Y; Jin Y; Gao JQ J Pharm Pharmacol; 2016 Mar; 68(3):333-41. PubMed ID: 26893058 [TBL] [Abstract][Full Text] [Related]
79. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation. Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858 [TBL] [Abstract][Full Text] [Related]
80. Combination of 7- Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]